UCLA's Capped Nanovials Enable Long-Term Cell Colonies for Drug Discovery

science

UCLA scientists have engineered capped nanovials that trap cells for days, allowing colonies to grow and interact, a breakthrough that could accelerate AI-driven drug discovery and high-throughput biomedical research.

The new system adds hydrogel sphere lids to existing bowl-shaped nanovials, self-assembling via molecular Velcro made of vitamin B7 and a bacterial protein, achieving up to 90% capping efficiency while still permitting nutrient flow.

Because the caps keep bacteria, yeast, and mammalian cells confined, researchers can now grow small colonies for hours to days, sort them by growth rate, and study cell-to-cell communication in a platform that works with standard lab equipment, opening the door to faster screening of antibiotics, biomanufacturing processes, and therapeutic antibodies.